IP Library Granted Patent US 7,932,056
Granted Patent B2
US 7,932,056 · App. 12/489,905 · Granted Apr 26, 2011

Crustaceans as production systems for therapeutic proteins

Assignee: Advanced Bionutrition
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,932,056
App. No.
12/489,905
Granted
Apr 26, 2011
Kind
B2
Abstract

A crustacean or rotifer is infected with a recombinant infectious virus that expresses a protein exogenous to the virus. The genome of the crustacean or rotifer itself remains unaltered. Crustacean, rotifer, insect, or viral promoters drive the transcription of a gene inserted into the recombinant virus genome, and the virus replicates in the crustacean or rotifer cell cytoplasm. The infected crustacean or rotifer can be provided directly to humans or non-human animals, or, following production and harvest of the crustaceans or rotifers, purified recombinant protein or polypeptide can be provided. Large quantities of biopharmaceuticals can be produced rapidly and inexpensively using this production system.

Claims (13)

1. A recombinant infectious virus selected from the group consisting of White Spot Syndrome Virus (WSSV) or Taura Syndrome Virus (TSV) comprising a nucleic acid encoding a polypeptide that is not native to said virus operably linked to a promoter that is active in a shrimp cell.

2. The virus of claim 1 , wherein the promoter is an exogenous promoter to said virus.

3. A method of producing a recombinant polypeptide comprising:

(a) infecting a shrimp with the virus according to claim 1 at a temperature permissive for infection that does not trigger viral injury;

(b) replicating the virus in one or more cells of said shrimp; and

(c) reducing the temperature of said shrimp of step (b) to a temperature that triggers increased replication of said virus and expression of said polypeptide that is not native to said virus.

4. The method of claim 3 , wherein the temperature permissive for infection is at or above about 30° C.

5. The method of claim 3 , wherein the temperature of step (c) is at or below about 28° C.

6. The method of claim 3 , wherein the polypeptide that is not native to said virus is an antibody, an antibody fragment, or a hormone.

7. A method of producing an antigen in a shrimp comprising:

(a) infecting a shrimp with the virus according to claim 1 at a temperature permissive for infection, wherein the polypeptide that is not native to the virus is an antigen;

(b) replicating the virus in one or more cells of said shrimp; and

(c) reducing the temperature of said shrimp to a temperature that triggers increased replication of said virus and expression of said antigen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2017
From: ADVANCED BIONUTRITION CORP.
To: INTERVET INC.
Reel/Frame 043120/0550 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 042242 FRAME: 0058. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 29, 2017
From: ADVANCED BIONUTRITION CORPORATION
To: ADVANCED BIONUTRITION CORP.
Reel/Frame 043050/0413 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2017
From: BARRATT, RUTH; ALLNUTT, F.C. THOMAS; BULLIS, ROBERT; KYLE, DAVID J.
To: ADVANCED BIONUTRITION CORP.
Reel/Frame 042242/0058 →
Continuity (5)
Division 10778175 · Feb 17, 2004
Continuation In Part PCTUS0229081 · Sep 13, 2002
Provisional Application 60168867 · Sep 14, 2001
Provisional Application 60473928 · May 29, 2003
Related Publication 20090258396A1 · Oct 15, 2009